OFIX
Orthofix Medical Inc.
NasdaqGSUSDEQUITY
Healthcare
DELAYED
Sell
-21/100
Last price
9.41
▼ 0.09 (0.95%)
MARKET · —
Price
Chart style
Interval
Intraday intervals only cover recent history. The site picks the finest interval the range allows.
Overlays
Session levels
Lower pane
Overlay another symbol
Both series are rebased to 0% at the left edge, so the lines show relative performance rather than price.
Tool
1D
—
H —
L —
Range —
Vol —
vs
Drag pan · Pinch zoom · Hold crosshair · pick a tool then drag to draw
Open
9.60
Prev close
9.50
Day high
9.59
Day low
9.38
Volume
392.83K
Market cap
$380.37M
P/E (TTM)
—
52W range
8.50 – 16.99
Day trading desk
Gap from prior close
+1.09%
Prior close 9.50
VWAP
9.44
-0.30% from price
Relative volume
1.93×
Unusually busy
Session range
2.38%
9.38 – 9.60
Position in range
13%
Near session low
ATR (14D)
0.41
4.40% of price
Prior day high
9.54
PDH
Prior day low
9.01
PDL
Bid / ask spread
—
Quote not published
Session volume
708.34K
Avg 366.34K
VWAP and the session figures are computed from the delayed intraday series on this page, so they lag the live tape and will not match a broker's real-time VWAP exactly. Turn on Prior day H/L/C, Opening range and Volume profile in the chart's Studies menu to see these levels drawn on price.
Trailing performance
Returnvs SPY
1W
-3.49%
-5.4%
1M
+1.29%
+0.1%
3M
-18.46%
-23.0%
6M
-19.64%
-37.8%
YTD
-37.93%
-52.2%
1Y
-35.59%
-52.0%
3Y
-26.83%
-109.1%
5Y
—
—
Price return only. Dividends are not reinvested, so total return on a dividend payer will be higher than shown.
Unusual options activity
Nothing crossed the thresholds in the expiries we scanned.
That is the normal state — most contracts trade well inside their existing open interest.
That is the normal state — most contracts trade well inside their existing open interest.
Contracts trading at or above their open interest, ranked by notional and where the print landed.
Free account
5 more panels on OFIX open with an account.
Options chains and analytics, valuation ratios, insider filings, analyst targets and ownership. No card, no trial, nothing to cancel.
Insider net activity
Net shares
+389.33K
Net buying
Buy transactions
12
640.34K shares
Sell transactions
6
251.01K shares
Net transactions
+18
Buys less sells
Sell : buy shares
0.4 : 1
Mixed
Insider-held shares
885.53K
Total on file
Insider transactions
| Date | Insider | Action | Shares | Value | Held |
|---|---|---|---|---|---|
| Oct 1, 26 | FISHER PATRICK G Officer |
SELL | 150 | $1.42K | Direct |
| Sep 21, 26 | JUNIPER INVESTMENT COMPANY, LLC Beneficial Owner of more than 10% of a Class of Security |
BUY | 310.00K | $2.73M | Indirect |
| Sep 1, 26 | FISHER PATRICK G Officer |
SELL | 150 | $1.41K | Direct |
| Aug 18, 26 | FISHER PATRICK G Officer |
SELL | 1.29K | $13.07K | Direct |
| Jun 18, 26 | MCPHERRON AVIVA Officer |
SELL | 3.67K | $34.42K | Direct |
| Jun 10, 26 | BAZAAR ALAN LEE Director |
STOCK | 14.96K | $0 | Direct |
| Jun 10, 26 | HANNON JASON M Director |
STOCK | 14.96K | $0 | Direct |
| Jun 10, 26 | FINEGAN MICHAEL M Director |
STOCK | 20.72K | $0 | Direct |
| Jun 10, 26 | KUMMETH CHARLES R Director |
STOCK | 14.96K | $0 | Direct |
| Jun 10, 26 | PAOLUCCI MICHAEL E Director |
STOCK | 14.96K | $0 | Direct |
| Jun 10, 26 | HENNEMAN JOHN BELL III Director |
STOCK | 14.96K | $0 | Direct |
| Jun 10, 26 | CAPPS VICKIE LYNN Director |
STOCK | 14.96K | $0 | Direct |
| Jun 10, 26 | MANIAR SHWETA SINGH Director |
STOCK | 14.96K | $0 | Direct |
| Jun 10, 26 | BURRIS WAYNE C. Director |
STOCK | 14.96K | $0 | Direct |
What this is, and what it is not
These are SEC Form 4 filings — officers, directors and 10% owners reporting their own trades in the company's stock. Filing is due within two business days of the transaction, so this lags reality by days, and the provider adds its own lag on top.
A sale is not automatically bearish. Executives sell on scheduled 10b5-1 plans, to cover tax on vesting equity, and to diversify. Purchases with cash are generally the more informative signal, and they are far rarer.
This does not include congressional or senate trading. That comes from STOCK Act disclosures filed with the Senate eFD system and the House Clerk, which this data source does not carry.
Officer and director trades in their own stock, straight from Form 4 filings.
Insider holders
| Name | Relation | Shares held | Latest |
|---|---|---|---|
ANDREWS JULIE |
Chief Financial Officer | 88.75K | Sale |
CALAFIORE MASSIMO |
Chief Executive Officer | 320.14K | Sale |
ENGINE CAPITAL MANAGEMENT, L.L.C. |
Beneficial Owner of more than 10% of a Class of Security | — | Purchase |
FINEGAN MICHAEL M |
Director | 81.62K | Stock Award(Grant) |
HANNON JASON M |
Director | 87.66K | Stock Award(Grant) |
HENNEMAN JOHN BELL III |
Director | 105.77K | Stock Award(Grant) |
JUNIPER INVESTMENT COMPANY, LLC |
Beneficial Owner of more than 10% of a Class of Security | — | Purchase |
KUMMETH CHARLES R |
Director | 76.31K | Stock Award(Grant) |
PAOLUCCI MICHAEL E |
Director | 102.73K | Stock Award(Grant) |
VITALE LUCAS S |
Chief Operating Officer | 160.45K | Sale |
Fundamentals
Market cap$380.37M
Enterprise value$541.38M
Revenue (TTM)$833.19M
Gross profit$593.73M
EBITDA$20.93M
Net income$-61.72M
EPS (TTM)$-1.51
Free cash flow$4.10M
Total cash$103.81M
Total debt$261.90M
Book value / share$10.54
Shares outstanding40.42M
Float40.41M
Short % of float6.95%
Dividend yield0.00%
Beta (5Y)0.62
Valuation & profitability ratios
Trailing P/E—
Forward P/E25.43
PEG ratio48.83
Price / sales—
Price / book0.89
EV / revenue0.65
EV / EBITDA25.87
Gross margin71.26%
Operating margin-3.26%
Profit margin-7.41%
Return on equity-13.91%
Return on assets-2.74%
Debt / equity61.02
Current ratio2.84
Fourteen ratios including P/E, PEG, EV/EBITDA, margins and return on equity.
Financial statements
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Total revenue | $822.31M | $799.49M | $746.64M | $460.71M | +2.9% |
| Operating revenue | $822.31M | $799.49M | $746.64M | $460.71M | +2.9% |
| Cost of revenue | $256.30M | $253.61M | $260.37M | $123.54M | +1.1% |
| Gross profit | $566.02M | $545.88M | $486.27M | $337.17M | +3.7% |
| Research & development | $65.85M | $73.64M | $80.23M | $49.06M | -10.6% |
| Selling, general & admin | $554.33M | $532.52M | $530.39M | $308.78M | +4.1% |
| Total operating expense | $648.59M | $623.60M | $628.03M | $366.04M | +4.0% |
| Operating income | -$82.57M | -$77.72M | -$141.76M | -$28.87M | -6.2% |
| Net interest income | -$17.49M | -$29.63M | -$8.63M | -$1.29M | +41.0% |
| Pre-tax income | -$90.81M | -$123.88M | -$148.68M | -$17.71M | +26.7% |
| Tax provision | $1.38M | $2.12M | $2.72M | $2.04M | -34.9% |
| Net income | -$92.19M | -$126.00M | -$151.40M | -$19.75M | +26.8% |
| Net income to common | -$92.19M | -$126.00M | -$151.40M | -$19.75M | +26.8% |
| Basic EPS | -2.33 | -3.30 | -4.12 | -0.98 | +29.4% |
| Diluted EPS | -2.33 | -3.30 | -4.12 | -0.98 | +29.4% |
| EBIT | -$73.32M | -$94.24M | -$140.05M | -$16.42M | +22.2% |
| EBITDA | $9.93M | -$18.28M | -$79.49M | $15.66M | +154.3% |
| Basic shares | 39.60M | 38.10M | 36.73M | 20.10M | +3.9% |
| Diluted shares | 39.60M | 38.10M | 36.73M | 20.10M | +3.9% |
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Cash & equivalents | $82.03M | $83.24M | $33.11M | $50.70M | -1.5% |
| Cash & short-term investments | $82.03M | $83.24M | $33.11M | $50.70M | -1.5% |
| Accounts receivable | $135.75M | $134.71M | $128.10M | $82.86M | +0.8% |
| Inventory | $172.32M | $189.45M | $222.17M | $100.15M | -9.0% |
| Total current assets | $416.85M | $433.29M | $420.44M | $255.99M | -3.8% |
| Property, plant & equipment | $129.40M | $139.80M | $159.06M | $58.23M | -7.4% |
| Goodwill & intangibles | $267.70M | $293.74M | $312.42M | $118.70M | -8.9% |
| Total assets | $850.65M | $893.29M | $925.32M | $458.63M | -4.8% |
| Total current liabilities | $170.48M | $168.63M | $165.22M | $83.62M | +1.1% |
| Current debt | — | — | $1.25M | — | — |
| Long-term debt | $157.39M | $157.01M | $93.11M | — | +0.2% |
| Total debt | $178.44M | $179.63M | $117.07M | $21.53M | -0.7% |
| Total liabilities | $400.61M | $390.17M | $326.58M | $121.77M | +2.7% |
| Retained earnings | -$368.33M | -$276.14M | -$150.14M | $1.25M | -33.4% |
| Shareholder equity | $450.04M | $503.12M | $598.73M | $336.86M | -10.6% |
| Working capital | $246.37M | $264.66M | $255.22M | $172.37M | -6.9% |
| Net tangible assets | $182.34M | $209.39M | $286.31M | $218.16M | -12.9% |
| Shares issued | 39.83M | 38.49M | 37.16M | 20.16M | +3.5% |
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Net income | -$92.19M | -$126.00M | -$151.40M | -$19.75M | +26.8% |
| Depreciation & amortisation | $83.25M | $75.96M | $60.56M | $32.08M | +9.6% |
| Stock-based compensation | $28.69M | $32.45M | $35.71M | $18.44M | -11.6% |
| Change in working capital | -$20.16M | -$19.25M | -$53.96M | -$44.14M | -4.7% |
| Operating cash flow | $33.35M | $25.79M | -$45.75M | -$11.54M | +29.3% |
| Capital expenditure | -$34.63M | -$34.88M | -$62.05M | -$23.16M | +0.7% |
| Investing cash flow | -$34.60M | -$27.58M | -$33.13M | -$24.53M | -25.4% |
| Financing cash flow | -$786.00K | $50.71M | $65.32M | -$78.00K | -101.6% |
| Free cash flow | -$1.28M | -$9.09M | -$107.80M | -$34.70M | +85.9% |
| End cash position | $85.11M | $85.74M | $37.76M | $50.70M | -0.7% |
| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | YoY |
|---|---|---|---|---|---|---|
| Total revenue | $210.93M | $196.71M | $219.91M | $205.63M | $203.12M | +7.2% |
| Operating revenue | $210.93M | $196.71M | $219.91M | $205.63M | $203.12M | +7.2% |
| Cost of revenue | $61.23M | $57.16M | $63.57M | $57.11M | $63.59M | +7.1% |
| Gross profit | $149.71M | $139.55M | $156.34M | $148.52M | $139.53M | +7.3% |
| Research & development | $15.94M | $15.32M | $15.37M | $14.77M | $15.93M | +4.1% |
| Selling, general & admin | $138.03M | $134.91M | $136.75M | $148.10M | $136.49M | +2.3% |
| Total operating expense | $156.97M | $153.23M | $155.19M | $166.00M | $156.30M | +2.4% |
| Operating income | -$7.27M | -$13.69M | $1.15M | -$17.47M | -$16.77M | +46.9% |
| Net interest income | -$6.08M | -$5.66M | -$4.35M | -$4.68M | -$3.95M | -7.4% |
| Pre-tax income | -$15.00M | -$20.83M | -$2.19M | -$22.26M | -$14.22M | +28.0% |
| Tax provision | $801.00K | $74.00K | $30.00K | $533.00K | -$142.00K | +982.4% |
| Net income | -$15.80M | -$20.91M | -$2.22M | -$22.80M | -$14.08M | +24.4% |
| Net income to common | -$15.80M | -$20.91M | -$2.22M | -$22.80M | -$14.08M | +24.4% |
| Basic EPS | -0.39 | -0.52 | -0.06 | -0.57 | -0.36 | +25.0% |
| Diluted EPS | -0.39 | -0.52 | -0.06 | -0.57 | -0.36 | +25.0% |
| EBIT | -$8.91M | -$15.17M | $2.16M | -$17.58M | -$10.27M | +41.3% |
| EBITDA | $5.45M | -$619.00K | $17.21M | -$3.06M | $7.72M | +980.3% |
| Basic shares | 40.91M | 40.40M | 40.00M | 39.80M | 39.50M | +1.3% |
| Diluted shares | 40.91M | 40.40M | 40.00M | 39.80M | 39.50M | +1.3% |
| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | YoY |
|---|---|---|---|---|---|---|
| Cash & equivalents | $103.81M | $120.28M | $82.03M | $62.86M | $65.61M | -13.7% |
| Cash & short-term investments | $103.81M | $120.28M | $82.03M | $62.86M | $65.61M | -13.7% |
| Accounts receivable | $135.82M | $137.78M | $135.75M | $130.81M | $129.56M | -1.4% |
| Inventory | $184.47M | $177.82M | $172.32M | $174.04M | $172.99M | +3.7% |
| Total current assets | $446.13M | $461.52M | $416.85M | $394.17M | $395.83M | -3.3% |
| Property, plant & equipment | $130.76M | $146.90M | $129.40M | $153.98M | $154.06M | -11.0% |
| Goodwill & intangibles | $260.91M | $264.27M | $267.70M | $270.57M | $273.80M | -1.3% |
| Total assets | $873.02M | $886.60M | $850.65M | $832.61M | $837.16M | -1.5% |
| Total current liabilities | $157.01M | $161.03M | $170.48M | $159.85M | $148.38M | -2.5% |
| Long-term debt | $221.59M | $221.34M | $157.39M | $157.22M | $157.05M | +0.1% |
| Total debt | $234.62M | $262.25M | $178.44M | $204.48M | $204.74M | -10.5% |
| Total liabilities | $443.84M | $451.42M | $400.61M | $390.12M | $378.81M | -1.7% |
| Retained earnings | -$405.04M | -$389.24M | -$368.33M | -$366.11M | -$343.32M | -4.1% |
| Shareholder equity | $429.18M | $435.19M | $450.04M | $442.49M | $458.35M | -1.4% |
| Working capital | $289.12M | $300.49M | $246.37M | $234.32M | $247.45M | -3.8% |
| Net tangible assets | $168.27M | $170.92M | $182.34M | $171.91M | $184.54M | -1.5% |
| Shares issued | 40.73M | 40.38M | 39.83M | 39.52M | 39.48M | +0.9% |
| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | YoY |
|---|---|---|---|---|---|---|
| Net income | -$15.80M | -$20.91M | -$2.22M | -$22.80M | -$14.08M | +24.4% |
| Depreciation & amortisation | $14.36M | $14.55M | $15.05M | $14.52M | $18.00M | -1.3% |
| Stock-based compensation | $7.74M | $6.53M | $7.21M | $7.18M | $7.82M | +18.4% |
| Change in working capital | -$22.85M | -$22.39M | $3.28M | $9.34M | -$10.46M | -2.1% |
| Operating cash flow | -$6.22M | -$17.61M | $27.70M | $12.40M | $11.64M | +64.7% |
| Capital expenditure | -$12.65M | -$10.66M | -$10.88M | -$9.90M | -$7.11M | -18.6% |
| Investing cash flow | -$12.65M | -$10.52M | -$10.87M | -$9.89M | -$7.10M | -20.3% |
| Financing cash flow | $2.45M | $63.97M | $2.38M | -$5.15M | $2.64M | -96.2% |
| Free cash flow | -$18.87M | -$28.27M | $16.82M | $2.50M | $4.53M | +33.2% |
| End cash position | $104.41M | $120.87M | $85.11M | $65.95M | $68.69M | -13.6% |
Options analytics
Put / call volume
—
—
Put / call open interest
—
Positioning, not flow
Max pain
10.00
+6.3% from spot
ATM implied vol
—
Nearest strike to spot
Skew (10% OTM)
—
—
Call volume
0
Contracts, this expiry
Put volume
8
Contracts, this expiry
Heaviest call OI
—
—
Heaviest put OI
10.00
7 contracts
Max pain is the strike at which the largest dollar value of open contracts expires worthless. It describes current positioning; it is not a forecast and it moves as open interest changes.
Put/call ratios, max pain, implied volatility skew and where open interest is concentrated.
Earnings
Reported vs expected · EPS
| Quarter | Est. | Actual | Surprise |
|---|---|---|---|
| Jun 2026 | -0.03 | 0.07 | +334.0% |
| Mar 2026 | -0.29 | -0.11 | +61.0% |
| Dec 2025 | 0.42 | 0.24 | -42.7% |
| Sep 2025 | 0.12 | 0.20 | +64.7% |
Forward consensus
| Period | EPS | Analysts | Revenue | Growth |
|---|---|---|---|---|
| Current quarter | 0.11 | 1 | $210.70M | +2.5% |
| Next quarter | 0.35 | 1 | $232.75M | +5.8% |
| Current year | 0.41 | 1 | $850.96M | +3.5% |
| Next year | 0.37 | 1 | $871.92M | +2.5% |
Analyst targets & ownership
Mean target$13.00
High target$14.00
Low target$12.00
Implied upside38.15%
Analyst count4
ConsensusNONE
Strong buy / Buy1 / 2
Hold2
Sell / Strong sell0 / 0
Held by insiders2.17%
Held by institutions95.80%
Institutions holding196
Price targets, consensus spread, insider and institutional ownership.
Moving averages & technicals
SMA 10
9.40
+0.12% from price
SMA 20
9.14
+2.90% from price
SMA 50
9.87
-4.64% from price
SMA 100
10.16
-7.37% from price
SMA 200
11.62
-19.00% from price
EMA 12
9.32
+0.92% from price
EMA 26
9.39
+0.16% from price
EMA 50
9.70
-3.00% from price
RSI (14)
50.1
Neutral
MACD (12,26,9)
-0.07
Hist 0.08
ATR (14)
0.41
4.40% of price
Realised vol 30D
33.9%
Annualised
Bollinger upper
9.79
20, 2σ
Bollinger lower
8.50
20, 2σ
50 / 200 cross
Death
9.87 vs 11.62
Trend bias
Below 200
-19.00%
Options chain
Calls
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Puts
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Every listed expiry, both sides of the book, with volume, open interest and implied volatility.
Risk profile
Beta vs SPY
0.69
Less volatile than market
Correlation to SPY
0.19
Largely independent
Realised vol 30D
33.9%
Annualised
Market vol 1Y
13.0%
SPY, annualised
Max drawdown 1Y
-46.8%
Peak to trough
Max drawdown 5Y
-77.6%
Peak to trough
ATR 14
0.41
4.40% of price
Beta (reported)
0.62
5Y monthly, from filing
Short interest
Shares short
2.51M
Prior 2.07M
Change vs prior
+20.8%
Shorts adding
% of float
6.95%
Normal
% of shares out
6.15%
Against total outstanding
Days to cover
8.2
Crowded exit
Float
40.41M
Freely tradeable shares
Exchanges publish short interest twice a month with a settlement lag, so this is roughly two weeks behind. Days to cover divides shares short by average daily volume — it estimates how long covering would take, not whether it will happen.
Rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Aug 10, 26 | Canaccord Genuity | MAINTAINED | Buy | Buy |
| Jul 6, 26 | Barrington Research | MAINTAINED | Outperform | Outperform |
| May 22, 26 | Canaccord Genuity | MAINTAINED | Buy | Buy |
| May 22, 26 | Barrington Research | MAINTAINED | Outperform | Outperform |
| May 22, 26 | Stifel | MAINTAINED | Buy | Buy |
| Apr 10, 26 | Barrington Research | MAINTAINED | Outperform | Outperform |
| Mar 9, 26 | Stifel | MAINTAINED | Buy | Buy |
| Feb 26, 26 | Canaccord Genuity | MAINTAINED | Buy | Buy |
| Feb 25, 26 | Barrington Research | MAINTAINED | Outperform | Outperform |
| Feb 17, 26 | Barrington Research | MAINTAINED | Outperform | Outperform |
| Jan 27, 26 | TD Cowen | INITIATED | — | Hold |
| Nov 5, 25 | Barrington Research | MAINTAINED | Outperform | Outperform |
Dividends & splits
Forward rate—
Forward yield0.00%
5-year avg yield—
Payout ratio0.00%
Ex-dividend date—
Next pay date—
Last split—
Split date—
SEC filings
Corporate Changes & Voting Matters
8-K · 2026-08-05
Corporate Changes & Voting Matters
8-K · 2026-07-02
Corporate Changes & Voting Matters
8-K · 2026-06-11
Specialized Disclosure Report filed pursuant to Section 1502 of the Dodd-Frank Wall Street Reform and Consumer Protection Act relating to the use of conflict minerals (Rule 13p-1)
SD · 2026-05-29
Corporate Changes & Voting Matters
8-K · 2026-05-21
Periodic Financial Reports
10-Q · 2026-05-05
Proxy Statements
DEFA14A · 2026-04-29
Corporate Changes & Voting Matters
8-K · 2026-04-09
Headlines
Orthofix Medical (OFIX) Stock Sees Fair Value Cut After Analysts Trim Q2 Outlook
Simply Wall St. · 44d ago
Orthofix Medical Sees Reimbursement Rebound, but Spine Slump Clouds Outlook
MarketBeat · 52d ago
Orthofix (OFIX) Q2 2026 Earnings Call Transcript
Motley Fool · 55d ago
Barrington Research Adjusts Orthofix Medical PT to $14 From $17, Maintains Outperform Rating
MT Newswires · 62d ago
Orthofix Medical Inc (OFIX) (Q2 2026) Earnings Call Highlights: Strategic Moves and Raised ...
GuruFocus.com · 62d ago
Orthofix Medical Q2 Earnings Call Highlights
MarketBeat · 62d ago
Orthofix Medical Inc. Q2 2026 Earnings Call Summary
Moby · 62d ago
Orthofix (OFIX) Q2 Earnings and Revenues Surpass Estimates
Zacks · 63d ago
PRIVATE STRATEGY · BY QUALIFICATION
The same data. A different seat.
The research you are reading is the input layer for a discretionary options program we run for a small number of qualified investors. Minimum $1,000,000.